GSK strikes deal to cut drug prices with US government GSK has struck a voluntary agreement with the US government to lower the cost of prescription medicines and expand access to treatments for millions of Americans. The move comes as pressure mounts on global drugmakers over pricing, tariffs, and domestic investment. The London-listed pharma giant said the deal covers medicines used by over 40m US [...]
Trump slaps 100 per cent tariff on imported drugs pharma US President Donald Trump announced a new round of tariffs on Thursday evening, with the pharmaceutical industry expected to be the hardest hit. Trump revealed that the US will impose a 100 per cent tariff on imported branded drugs, a 25 per cent tariff on all heavy-duty truck imports, a 50 per cent tariff on [...]
Glastonbury weekend: drugs testing can save lives this festival season Opinion No matter what organisers do, there will always be drugs at festivals like Glastonbury, so why not make sure they are as safe as possible? Asks Sacha Lord This weekend will see the doyenne of festivals, Glastonbury, will fire the starting gun on the summer party season. At every single major festival in the UK [...]
The Debate: Should the UK decriminalise cannabis? June 4, 2025 Sadiq Khan says yes, but is the UK really ready for looser rules around cannabis? We get two experts to argue for and against.
Sadiq Khan backs calls to decriminalise cannabis possession May 28, 2025 A report commissioned by Sadiq Khan has called for decriminalising the possession of cannabis in small quantities, in a major policy pivot for City Hall. The London Drugs Commission, which was set up by the Mayor of London two years ago, argues that while the production and supply of cannabis should continue to “be policed [...]
GSK and Astrazeneca shares slump as Trump vows drug price cut May 12, 2025 GSK and Astrazeneca shares fall as Trump announces drug price cuts in a new executive order.
Astrazeneca chief blasts Europe for ‘putting citizens’ health at risk’ April 23, 2025 Europe is putting its “ability to protect the health of its own people at risk” by not investing enough, the chief executive of FTSE 100 giant Astrazeneca has warned. Pascal Soriot added that the continent is “falling behind” in attracting R&D and manufacturing investment and needs to “invest more in what really matters to it”. [...]
GSK shares rise after £1.7bn Zantac settlement October 10, 2024 GSK shares have spiked today after the pharmaceutical giant agreed to pay as much as $2.2bn (£1.68bn) to settle lawsuits alleging one of its heartburn drugs had caused cancer. The discontinued version of the drug, Zantac, had triggered 80,000 lawsuits from 10 different law firms in the US and has hung over the FTSE 100 [...]
Fusion Antibodies: Pharma firm has ‘challenging’ year despite strong sales pipeline September 5, 2024 Pharmaceutical company Fusion Antibodies said it had a “challenging” year but has seen its sales pipeline grow. Fusion posted audited revenue of £1.14m for the year ended March 2024, a 60 per cent drop from the £2.9m it reported in 2023. The company, which specialises in antibody discovery, engineering and supply for therapeutic drugs, said [...]
Horny Brew and Jerk Off Chicken on list of names rejected by Companies House June 20, 2024 'Reverse Cowgirl Riding School', 'Hashhunter Limited' and 'Beasts of Bondage' are three of the more than 700 company names that have recently been rejected by Companies House.